Efficacy of Bevacizumab in the First-Line Treatment of Patients with RAS Mutations Metastatic Colorectal Cancer: a Systematic Review and Network Meta-Analysis

Publisher: Karger

E-ISSN: 1421-9778|40|1-2|361-369

ISSN: 1015-8987

Source: Cellular Physiology and Biochemistry, Vol.40, Iss.1-2, 2016-11, pp. : 361-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content